Maximizing market potential with target patient population analysis

The challenge

Our client sought to understand both pediatric and adult patient populations for a rare disease, focusing on the number of actively treated patients by demographic, treatment paradigm, insurance coverage, and competitive dynamics to optimize patient targeting for market entry and growth.

The client needed to identify key treatment gaps and understand the distinct market conditions for each patient group to ensure a strategic and successful launch while positioning the treatment for long-term growth.

The Acumetis approach

Acumetis partnered with the client to conduct a comprehensive target patient population analysis designed to quantify market opportunity and refine commercialization strategy across pediatric and adult patient populations.

Pediatric and adult patient population analysis

Conducted a detailed demographic analysis of pediatric and adult patient populations, assessing disease prevalence, actual prevalence, number of actively treated patients, and treatment accessibility.

Treatment gap identification

Identified critical treatment gaps, providing insights into how a new treatment could address unmet needs in both age groups.

Competitive landscape evaluation

Analyzed the competitive landscape, focusing on product offerings, market share, and strategic moves of competitors, with a specific focus on differences between pediatric and adult patient segments.

Rare disease market dynamics assessment

Evaluated factors specific to the rare disease, including regulatory incentives and the impact of patient advocacy.

Strategic market entry planning

Developed a strategic market entry plan based on these insights, optimizing positioning for long-term growth.

The outcome

The engagement provided the client with a clearer understanding of market opportunity across pediatric and adult patient populations within the rare disease landscape. By connecting demographic analysis, treatment accessibility, competitive dynamics, and market intelligence, the client strengthened its ability to refine commercialization strategy, identify unmet needs, and support long-term market positioning.

Why it worked

• Conducted a detailed demographic analysis of pediatric and adult patient populations, assessing disease prevalence, actual prevalence, number of actively treated patients, and treatment accessibility.
• Identified critical treatment gaps, providing insights into how a new treatment could address unmet needs in both age groups.
• Analyzed the competitive landscape, focusing on product offerings, market share, and strategic moves of competitors, with a specific focus on differences between pediatric and adult patient segments.
• Evaluated factors specific to the rare disease, including regulatory incentives and the impact of patient advocacy.
• Developed a strategic market entry plan based on these insights, optimizing positioning for long-term growth.

Acumetis insights and analytics team

Rare and specialty markets require granular insight and expert interpretation to uncover the hidden insights that others can’t see. Our proprietary information platforms deliver patient-level granularity across rare and specialty indications creating transparency in markets that are otherwise opaque. But data alone doesn’t drive strategy. Our senior experts translate those signals into clear, defensible recommendations that sharpen decisions across medical, access, and commercial teams. The result: a clearer picture of what’s happening in your market, smarter prioritization of where to act, and decisions your team can stand behind. Meet with our experts to learn more about our team.